Sign Up to like & get
recommendations!
1
Published in 2022 at "Clinical Pharmacology in Drug Development"
DOI: 10.1002/cpdd.1173
Abstract: This study evaluated the safety, pharmacokinetic parameters, and bioequivalence (BE) of pomalidomide (POM) capsules (specification: 4 mg) acquired from 2 sponsors (test [T] and reference [R]), under fasting and fed conditions. A single‐center, randomized, open‐label,…
read more here.
Keywords:
single dose;
fasting fed;
fed states;
concentration ... See more keywords